Copper-containing mesoporous bioactive glass nanoparticles as multifunctional agent for bone regeneration by Bari, Alessandra et al.
Accepted Manuscript
Copper-containing mesoporous bioactive glass nanoparticles as multifunctional
agent for bone regeneration
Alessandra Bari, Nora Bloise, Sonia Fiorilli, Giogia Novajra, Maria Vallet-
Regí, Giovanna Bruni, Almudena Torres-Pardo, José M. González-Calbet, Livia
Visai, Chiara Vitale- Brovarone
PII: S1742-7061(17)30240-4
DOI: http://dx.doi.org/10.1016/j.actbio.2017.04.012
Reference: ACTBIO 4836
To appear in: Acta Biomaterialia
Received Date: 11 January 2017
Revised Date: 13 March 2017
Accepted Date: 11 April 2017
Please cite this article as: Bari, A., Bloise, N., Fiorilli, S., Novajra, G., Vallet-Regí, M., Bruni, G., Torres-Pardo,
A., González-Calbet, J.M., Visai, L., Vitale- Brovarone, C., Copper-containing mesoporous bioactive glass
nanoparticles as multifunctional agent for bone regeneration, Acta Biomaterialia (2017), doi: http://dx.doi.org/
10.1016/j.actbio.2017.04.012
This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers
we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and
review of the resulting proof before it is published in its final form. Please note that during the production process
errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.
  
1 
 
Copper-containing mesoporous bioactive glass nanoparticles as 
multifunctional agent for bone regeneration. 
 
Alessandra Baria †, Nora Bloise b,c †, Sonia Fiorillia, Giogia Novajraa, Maria Vallet-Regíd, , Giovanna 
Brunie, Almudena Torres-Pardof, José M. González-Calbetf, Livia Visaib,c, Chiara Vitale- Brovarone*a 
 
 
a Department of Applied Science and Technology, Politecnico di Torino, Corso Duca degli Abruzzi 
24, 10129 Torino, Italy 
b Molecular Medicine Department (DMM), Center for Health Technologies (CHT), UdR INSTM, 
University of Pavia, Viale Taramelli 3/B – 27100 Pavia – ITALY 
c Department of Occupational Medicine, Toxicology and Environmental Risks, Istituti Clinici 
Scientifici Maugeri S.p.A, IRCCS, Via S. Boezio, 28 - 27100 Pavia – ITALY  
d Departamento de Química Inorgánica y Bioinorgánica, Universidad Complutense de Madrid, 
CIBER de Bioingeniería, Biomateriales y Nanomedicina (CIBER-BBN), Plaza Ramón y Cajal s/n, 
28040 Madrid, Spain  
e Department of Chemistry, Section of Physical Chemistry, University of Pavia, Italy. 
f Departamento de Química Inorgánica, Facultad de Químicas, Universidad Complutense de Madrid, 
28040 Madrid, Spain  
 
* Corresponding Author: Tel: +39 011 5644716; E-mail: chiara.vitale@polito.it 
† 
equal contribution 
Keywords: Mesoporous bioactive glasses; Copper; Bone repair; Antibacterial activity; Biofilm 
 
Abstract  
The application of mesoporous bioactive glasses (MBGs) containing controllable amount of different 
ions, with the aim to impart antibacterial activity, as well as stimulation of osteogenesis and 
angiogenesis, is attracting an increasing interest.  
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In this contribution, in order to endow nano-sized MBG with additional biological functions, the 
framework of a binary SiO2-CaO mesoporous glass was modified with different concentrations of 
copper ions (2 and 5% mol.), through a one-pot ultrasound-assisted sol-gel procedure. The Cu-
containing MBG (2% mol.) showed high exposed surface area (550 m2 g-1), uniform mesoporous 
channels (2.6 nm), remarkable in vitro bioactive behaviour and sustained release of Cu2+ ions.  
Cu-MBG nanoparticles and their ionic dissolution extracts exhibited antibacterial effect against three 
different bacteria strains, E. coli, S. aureus, S. epidermidis, and the ability to inhibit and disperse the 
biofilm produced by S. epidermidis. 
The obtained results suggest that the developed material, which combines in single multifunctional 
agent excellent bioactivity and antimicrobial ability, offers promising opportunities for the prevention 
of infectious diseases and the effective treatment of bone defects. 
 
1. Introduction 
Bone tissue shows an intrinsic potential of self-healing in response to injury [1]. However, the 
effective treatment of bone defects, especially the larger one resulting from impaired bone 
regeneration, compromised regenerative process such as osteoporosis or due to trauma, infection or 
tumour resection, still represents a challenging clinical issue [2]. To this aim, in the last decades, a 
wide class of bioactive materials have been proposed as bone-tissue regeneration systems [3,4].  
Recently, one of the most appealing approach to design novel biomaterials for bone repair is to 
combine in a single multifunctional component several abilities, including osteoconductivity (for 
guidance of new bone growth) and the capacity to stimulate both osteogenesis (for promoting new 
bone formation) and angiogenesis (for inducing vascularization) [5-7]. Furthermore, bone healing is 
also substantially hindered when infection occurs, mainly after an open fracture. Conventional 
treatments include systemic antibiotic administration, surgical debridement or wound drainage [8]. 
These actions, however, are often ineffective and may result in quite serious complications leading to 
extra surgeries, with a consequent high burden in terms of pain and social costs. Consequently, the 
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development of bioactive materials enabled with antibacterial properties would represent a valuable 
solution in preventing post-surgical infections. 
In the field of advanced bioceramics, mesoporous bioactive glasses (MBGs), which combine the 
textural parameters of ordered mesoporous matrices with the properties of conventional bioactive sol-
gel glasses, have received increasing attention as bone-tissue regeneration systems [8-14]. The unique 
textural properties of these templated-glasses, synthesized mostly in the systems SiO2-CaO or SiO2-
CaO-P2O5, lead to significantly enhanced bioactivity compared with conventional bioactive glasses, 
making them ideal components for bone regeneration. More recently, the application field of MBGs 
has moved a big step forward by including controllable amount of different ions in their composition. 
In particular, the final aim is to impart other biological functions, including anti-bacterial activity, as 
well as stimulation of osteogenesis and angiogenesis, by means of the incorporation of metallic 
elements with therapeutical effect [15, 16]. Furthermore, the large exposed surface area and the 
accessible pore volume shown by MBGs provide excellent drug delivery ability, which 
synergistically combined with the release of therapeutic ions, can be exploited for the development of 
multifunctional biomaterials. In the past five year, different therapeutic ions, including Ag+, Sr2+, Cu2+ 
and Co2+ have been incorporated into MBG-based scaffolds and their release had been related to the 
enhancement of several biological functions [17-21]. In particular, the release of Sr2+ ions from Sr-
containing MBG scaffolds was found to significantly stimulate new bone formation in osteoporotic 
bone defects in vivo [22] and MBG scaffolds incorporating Co2+ and Cu2+ ions have been reported to 
promote angiogenesis in vitro and in vivo [23].  
Some recent studies have focussed on the development of MBG particles characterized by size 
ranging from ten to hundreds of nanometres and by excellent surface bioreactivity [24]. This class of 
nanostructured materials is extremely attractive in relation to regenerative medicine, as it allows to 
widen the use of MBGs, including the design of nanocomposite with biopolymers, the dispersion as 
active phase in injectable gels or the production of functional coatings on different materials (porous 
ceramics, metals) to combine improved mechanical properties and high bioactivity [25-28]. El-Fiqi et 
al. [29] have recently attained, through an ultrasound-assisted sol-gel process, the preparation of 
MBG nanoparticles with binary SiO2-CaO composition, and had shown their capacity to act as 
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delivery nanovehicles of therapeutic molecules, along with excellent apatite forming ability and good 
cell viability.  
In this work, with the aim to endow nano-sized MBGs with additional biological functions, the 
framework of a binary SiO2-CaO system was modified with different amount of copper ions, due the 
recognized therapeutic properties of this element. Indeed, the sustained release of Cu2+ ions, as 
hypoxia-mimicking ion, is known to enhance bone density by inhibiting active bone resorption [30, 
31]. Furthermore, very recently, a systematic evaluation of copper-doped mesoporous silica 
nanospheres, through in vitro biological assessment under immune environment, have finely 
evidenced that these nanomaterials can induce osteogenic/angiogenic factors and suppress 
osteoclastogenic factors by immune cells, evidencing their potential as immunomodulatory agent for 
tissue regeneration/therapy applications [32]. Copper is also recognized to be an antimicrobial agent 
[17], a crucial aspect for an effective bone repair process.  
In this contribution, the insertion of Cu ions within the framework of a mesoporous SiO2-CaO 
bioglass was carried out through a one-pot ultrasound-assisted sol-gel procedure. The effect of copper 
insertion on the textural features and the in vitro bioactive response of the resulting systems were 
assessed, along with the Cu2+ release profiles. The antibacterial properties of the synthesized copper 
containing MBG and their ionic extracts were tested using different bacterial strains. Furthermore, the 
ability in inhibiting and dispersing the biofilm produced by the Staphylococcus epidermidis was 
investigated. 
 
2. Materials and methods 
2.1 Preparation of Cu-containing MBGs 
Copper-loaded MBGs were synthesized through an ultra-sound assisted base catalysed sol-gel 
method, by incorporating Cu into the MBG framework to replace part of calcium (Ca). MBG with 2% 
molar percentage of Cu (molar ratio Cu/Ca/Si=2/13/85, named: Cu_MBG 2%) and 5% molar 
percentage of Cu (molar ratio Cu/Ca/Si=5/10/85, named: Cu_MBG 5%) were prepared by the same 
method. Briefly, 5 g of cetyltrimethylammonium bromide (CTAB, ≥98%, Sigma) was completely 
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dissolved by stirring in 120 mL of absolute methanol, whose pH was adjusted to 12.5 by adding about 
30 mL NH4OH. Into this solution, proper amounts of calcium nitrate tetrahydrate (Ca(NO3)2∙	4H2O, 
99%) and copper chloride (CuCl2, 99%) were dissolved. In a separate batch, 0.895 g tetraethyl 
orthosilicate (TEOS, 99%) were dissolved in 30 mL absolute methanol and was then added to the first 
solution with the simultaneous application of ultra-sound using a SONOPULS Ultrasonic 
Homogenizers HD 3200. The output power was 150 W in a 10s on/10s off cycle for 20 min. This 
solution was stirred at room temperature for 24 h. Then the precipitate was separated by 
centrifugation at 5000 rpm for 5 min, washed one time with distilled water and two times with 
absolute ethanol. The final precipitate was dried at 70°C for 12h and calcined at 600°C in air for 5 h 
at a heating rate of 1°C min-1 using a Carbolite 1300 CWF 15/5. A sample without Cu (molar ratio 
Si/Ca=85/15, named MBG) was also prepared by the same method and used as reference system. 
2.2 Materials Characterization  
The morphology of the synthesized nanoparticles was analysed by Field-Emission Scanning Electron 
Microscopy (FE-SEM) microscopy using a Philips 525M instrument. Compositional analysis of the 
powders was performed by energy dispersive spectroscopy (EDS; Philips Edax 9100).  
The samples were characterized by X-ray diffraction (XRD) through a Philips X'pert diffractometer 
(Cu Kα radiation) and nitrogen adsorption measurements at 77 K performed using a Quantachrome 
Autosorb 1. Samples were outgassed at 423 K for 5 hours before analysis. BET specific surface areas 
have been calculated in the relative pressure range 0.04–0.1 and the pore size has been evaluated 
through the DFT (Density Functional Theory) method, using the NLDFT equilibrium model for 
cylindrical pore  
High Resolution Transmission Electron Microscopy (HRTEM) imaging and local EDS spectroscopy 
was performed on a JEOL JEM300FEG electron microscope equipped with an ISIS 300 X-ray 
microanalysis system (Oxford Instruments). Cu_MBG 2% and Cu_MBG 5% samples were 
ultrasonically dispersed in n-butanol and transferred to carbon coated nickel grids to analyze the 
copper distribution in the nanospheres. 
A PHI 5000 Versaprobe II Scanning X-ray Photoelectron Spectrometer (XPS), equipped with a 
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monochromatic Al K-alpha X-ray source (1486.6 eV energy, 15 kV voltage and 1 mA anode current), 
was used to investigate the surface chemical composition. A spot size of 100 micron was used in 
order to collect the photoelectron signal for both the high resolution (HR) and the survey spectra. 
Different pass energy values were exploited: 187.85 eV for survey spectra and 23.5 eV for HR peaks. 
The core level spectra were deconvoluted with a nonlinear iterative least squares Gaussian fitting 
procedure. 
2.3 Evaluation of Cu ion release  
In order to evaluate Cu ion release, 30 mg of copper-containing samples were placed in a plastic 
container with 30 mL of SBF (final concentration of 1 mg/mL of SBF) prepared according to Kokubo 
recipe [33]. The samples were kept immersed for different times up to 7 days at 37°C in an orbital 
shaker IKA KS 4000 with an agitation rate of 150 rpm. At each time point, the suspension was 
centrifuged and 1 mL of the supernatant solution was collected and analysed by inductively coupled 
plasma atomic emission spectrometry technique (ICP-AES) through the ICPMS Thermoscientific 
ICAPQ spectrometer. 
2.4 Bioactivity assessment  
In vitro bioactivity was assessed by using the methodology described in ref [34], where a unified 
method for the evaluation of HA-forming ability of bioactive glasses in powder form is proposed. In 
particular, 30 mg of powders MBG and Cu_MBG 2% were soaked in 30 mL of SBF for 3h, 1, 3, 7 
and 14 days. The bottles were placed inside an orbital shaker IKA KS 4000 at a fixed temperature of 
37°C. At each selected time point, the powders were removed by centrifugation at 5000 rpm for 5 
min, rinsed with bi-distilled water and dried in oven at 70°C for 12h. The pH of SBF was measured at 
each time point. The powders were analysed by FESEM and by XRD to detect the HA phase 
formation. 
2.5 Antibacterial property of nanoparticles  
2.5.1 Bacterial strains and culture conditions 
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The microorganisms used in this study were Escherichia coli RB (E. coli RB), Staphylococcus aureus 
8325-4 (S. aureus 8325-4) and Staphylococcus epidermidis (S. epidermis RP62A), being the later a 
strong biofilm-producing strain [35, 36]. E. coli RB was provided by the “Zooprofilattico Institute of 
Pavia” (Italy) whereas S. aureus 8325-4 and S. epidermidis RP62-A were kindly supplied by Timothy 
J. Foster (Department of Microbiology, Dublin, Ireland). All bacteria strains were routinely grown in 
their culture medium overnight under aerobic conditions at 37°C using a shaker incubator (New 
Brunswick Scientific Co., Edison, NJ, USA): E. coli RB in Luria Bertani Broth (LB) (Difco, Detroit, 
MI, USA), S. aureus 8325-4 in Brian Heart Infusion (BHI) (Difco) and S. epidermidis RP62A in 
tryptic soy broth (TSB, Difco). These cultures were statically incubated at 37°C under aerobic 
conditions and reduced to a final density of 1 x1010 cells/mL as determined by comparing the optical 
density (OD600) of the sample with a standard curve relating OD600 to cell number.  
Two different experimental conditions were used to evaluate the antibacterial activity of un-doped 
and doped nanoparticles. For the first experimental condition, MBG or Cu_MBG 2% suspensions in 
sterile phosphate-buffered saline, (PBS: 137 mM NaCl, 2.7 mM KCl, 4.3 mM Na2HPO4, pH 7.4).) 
with a final concentration of 2 mg/mL were prepared, sonicated (ultrasonic bath, FALC Instruments, 
Italy) for 5 minutes at room temperature, and properly diluted to obtain concentrations of 31, 63, 125, 
250, 500, 1000 and 2000 µg/mL. The obtained suspensions were further sonicated for 5 minutes at 
room temperature prior to the direct incubation with bacterial cells.  
The second experimental condition was analogously performed, but in order to evaluate the 
antibacterial proprieties ascribable to the released Cu2+ ions from Cu_MBG 2%, un-doped and doped 
MBGs were dispersed in sterile PBS (2 mg/mL) and kept soaked for 3 h and 24 h, then centrifuged 
and the supernatants collected for antibacterial activity tests. Bacterial strains were incubated without 
(control) or with increasing serial dilutions of the extracts collected after 3 h and 24 h from the MBG 
and Cu_MBG 2% suspensions, respectively. The control samples of both the experimental conditions 
were performed by addition of the same volume of PBS. Each experiment condition was repeated 
three times.  
2.5.2 Evaluation of antibacterial effect on bacterial planktonic growth 
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For both experimental conditions, a predefined number (10^4/mL) of Gram negative (E. coli RB) and 
Gram positive (S. aureus 8325-4 and S. epidermidis RP62A) cells were incubated in their culture 
broth at 37°C in 96-well microtiter plates. For the first experimental condition, bacterial cells were 
untreated (control) or treated with nanoparticle suspensions at increasing concentrations, ranging from 
31 up to 2000 µg/mL, for 1 and 3 days, respectively. For the second experimental condition, bacterial 
cells were untreated (control) or treated with increasing serial dilutions of extracts previously 
collected at 3 and 24 h from of MBG or Cu_MBG 2% suspensions (2 mg/mL) and incubated for 1 
day.  
For both experimental conditions, at fixed incubation times, the quantitative 3-[4,5-dimethylthiazol-2-
yl]-2,5 diphenyl tetrazolium bromide (MTT Sigma Aldrich, St Louis, MO, USA) assay was 
performed to assess the dehydrogenase activity, as an indicator of the metabolic state of cells, as 
previously described [37]. The bacterial viability was expressed as percentage related to the control 
set equal to 100%. 
2.5.3 Evaluation of antibacterial effect on S. epidermidis biofilms  
For biofilm experiments, overnight culture of S. epidemidis RP62A was diluted in its broth culture 
medium with the addition of 0.25% glucose [38]. Aliquots (100 µL) of the diluted bacterial 
suspensions were inoculated into 96-well flat-bottom sterile polystyrene microplates (Costar, 
Corning, NY, USA) as follows: i. without (control) or with a suspension of 2 mg/mL of MBG or 
Cu_MBG 2% nanoparticles in PBS; ii. without (control) or with extracts collected after 24 h of 
incubation with MBG or Cu_MBG 2% suspension (2 mg/mL) in PBS. In both cases (i and ii) the 
experiments were performed in two different types of settings: a. nanoparticles suspensions or 
nanoparticles extracts were contemporarily incubated with biofilm growing cultures in order to 
evaluate their effects during biofilm formation; b. nanoparticles suspensions or nanoparticles extracts 
were added after the biofilm formation, to assess their effects on the formed biofilms. After fixed 
incubation times, biofilms were washed twice with PBS to remove planktonic cells and loosely 
adhering bacteria [39]. Viability quantification of microbial cells inhabiting the biofilms was 
performed by MTT test as described above.  
2.5.4 Scanning Electron Microscopy (SEM) of S. epidermidis biofilms 
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For morphological evaluation, biofilm untreated (control) or treated with nanoparticles suspensions or 
their extracts for both the experimental settings (as described above) were grown in plastic cell 
culture coverslip disks (Thermanox Plastic, Nalge Nunc International, Rochester, New York) seeded 
on the bottom of a 24-well culture plates and incubated for 24 h at 37°C. Briefly, the disks were 
washed several times and then fixed for SEM with 2.5% glutaraldehyde in 0.1M cacodylate buffer, 
pH 7.2 for 1h at 4 °C. After additional washes, they were incubated with increasing concentrations of 
ethanol (25%, 50%, 75% and 96%) for 10 min each, dried to the critical point using an Emitech K-
850 apparatus (Emitech, Ashford, Kent, UK) and placed on a mounting base [38]. Finally, the disks 
were coated with gold layer and examined through SEM analysis (Zeiss EVO-MA10 scanning 
electron microscope, Carl Zeiss, Oberkochen, Germany). 
2.5.5 Statistical Analysis  
All statistical calculation was carried out using GraphPad Prism 5.0 (GraphPad Inc., San Diego, CA). 
Statistical analysis was performed using Student’s unpaired t-test and through one-way variance 
analysis (ANOVA), followed by Bonferroni post hoc, for multiple comparisons (significance level of 
p≤ 0.05).  
 
3. Results  
3.1 The morphological and structural characterization of Cu_MBGs 
The morphology of mesoporous glass nanoparticles doped with defined concentrations of copper 
ions, was observed by high resolution FE-SEM. The images of Cu_MBG 2% (Figure 1.A) revealed 
particles with a uniform spheroidal morphology, with size ranging between 170 and 200 nm. Energy-
dispersive spectrometry analysis (EDS) confirmed the incorporation of Cu inside the framework: the 
detected Cu/Si molar ratio, as average of three measurements, resulted in fair agreement with the 
nominal ratio (Figure 1.B). 
TEM observations showed that the nanoparticles contain mesopores throughout their inner structure, 
in the form of a worm-like system (Figure 1.C). Quantitative analysis using EDS mapping, coupled to 
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TEM, was used to explore the element distribution in the sample and showed that Cu ions, like the 
other elements, were evenly distributed within the whole of the particle (Figure 1.D). 
FE-SEM observation of Cu_MBG 5% sample (Figure 1.E) showed spheroidal particles whose size 
ranges between 180-230 nm, on average slightly larger than what was observed for Cu_MBG 2%. 
EDS analysis reported in the inset of Figure 1.E showed the incorporation of copper with a molar 
concentration very close to the nominal ratio. TEM images of Cu_MBG 5%, (Figure 1.F) allowed 
discerning a core-shell morphology for this sample, with a shell characterized by a regular 
mesoporous structure and an internal core characterized by larger and irregular cavities. In this case, 
EDS mapping analysis evidenced different Si, Ca and Cu atomic percentages in the core and shell 
regions of the particles, showing, a higher concentration of Ca and Cu ions in the core (Ca/Si= 0.13 
and Cu/Si = 0.15) compared to the outer shell (Ca/Si= 0.05 and Cu/Si = 0.06).  
The mesoporous structure of Cu-modified MBGs systems was confirmed by the N2 adsorption-
desorption isotherms (Figure 2), which revealed that the isotherm curves of MBG, Cu_MBG 2% and 
Cu_MBG 5% had type-IV isotherm with a well-defined step at relative pressure (P/P0) below 0.3, 
indicative of the filling of uniform mesopores. The capillary condensation observed at higher relative 
pressures for Cu_MBG 5% (green curve) is ascribable to intra-particles voids or to the disordered 
porosity located in the particle core, discernible from TEM images.  
The values of BET specific surface area, mesopores volume and pore diameter for the investigated 
samples are reported in Table 1: a decrease of surface area and pore volume was found with 
increasing the amount of copper ion. The mesopore diameter was approximately 2.6 nm in the Cu-
containing samples, which is that typical of CTAB-templated systems.  
In the high-angle XRD patterns (Supplementary information, SI.1), the broad peak at 23° 
corresponded to amorphous silica, and no diffraction peaks of copper oxide (CuOx) were observed in 
these samples, indicating that the incorporated copper does not form oxide crystals.  
In order to investigate the nature of the copper species incorporated inside the glass framework, XPS 
spectra were recorded on Cu_MBG 2% and Cu_MBG 5%. Figure 3 shows the deconvoluted XPS 
spectra of Cu_MBG 2% and Cu_MBG 5% in the Cu2p3/2 region.  
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The components at 935.7 eV and 933.3 eV obtained through the deconvolution and their integrated 
peaks areas are reported in Table 2: an evident difference in the relative amount of the two 
components was found. 
3.2 Copper ion release from nanoparticles in SBF 
The ionic concentrations (µg/mL) of Cu2+ species in SBF medium after contact for 7 days with Cu-
containing powders are reported in Figure 4.  
In the case of Cu_MBG 2%, a sustained release of Cu2+ is observed over the 7 days of soaking and 
the percentage released resulted approximately 90%. Furthermore, the EDS analysis of the sample 
after the release tests did not reveal the presence of residual copper, suggesting a quantitative release 
of the functional ion. At variance, the release test carried out with Cu_MBG 5% evidenced a very low 
percentage of released Cu2+ (around 10%), suggesting that copper ions are mostly inaccessible. 
3.3 Bioactive behaviour of Cu_MGB 2% 
Based on the obtained release kinetics for Cu2+ species, the investigation about the bioactive 
properties was uniquely performed on Cu_MBG 2% and on MBG for comparison. 
Both samples showed a remarkable bioactivity when soaked in SBF. The precipitation of 
hydroxyapatite (HA) was assessed after only 3 hours of immersion and a conspicuous amount of it 
could be easily detected after 24 hours of soaking. 
Figure 5 shows FE-SEM images of Cu_MBG 2% nanoparticles after 3 (Figure 5.A) and 7 days 
(Figure 5.B) and related EDS spectra (Figure 5.D’ and 5.D’’) of SBF soaking: globe-shaped 
agglomerates are easily distinguishable on the nanoparticles surface. The phase nucleated after 3 h of 
soaking, as assessed by EDS analysis, can be identified as Ca-deficient HA (Ca/P = 1.51). The Ca 
content in the newly formed phase gradually rises as soaking time increases and after seven days, a 
molar Ca/P ratio of 1.62 was detected, which is in the range of calcium-deficient biological apatite. 
The pH of SBF remained in the physiological range during particles soaking (between 7.4 and 7.5) 
The WAXRD spectrum of the Cu_MBG 2% sample after 24 h of soaking in SBF is reported in Figure 
5.C. Marked peaks at 32° and 26° and other less intense reflections at about 40°, 47° and 49° were 
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assigned to the (0 0 2), (2 1 1), (3 0 0), and (2 1 3) reflections of HA (reference code 01-074-0565). 
The other narrow peaks are ascribable to calcite (reference code 01-083-1762).  
3.4 Antibacterial property of MBG nanoparticles and their extracts on bacterial 
planktonic growth 
In the present study, the synthesized nanoparticles (first experimental condition) and their extracts 
(second experimental condition) were tested for their antibacterial activity against human pathogenic 
bacteria, namely, E. coli RB, S. aureus 8325-4 and S. epidermidis RP62A (Figures 6 and 7). For the 
first condition (Figure 6), all the bacteria strains were incubated with different concentrations of both 
MBG and Cu_MBG 2% particles for 1 and 3 days of culture, respectively. The results in Figure 6 
evidenced a similar trend on all bacteria cultures after the incubation with the Cu_MBG 2% 
nanoparticles, showing that the bacterial growth suppression was clearly correlated to the presence of 
copper and its increasing availability for higher concentration. After 1 day of incubation with a 
concentration above 250 µg/mL, approximately 30-40% of growth inhibition was observed for all 
types of bacteria, in comparison to the control (cultures without nanoparticles). In particular, the 
obtained results showed that at longer incubation times (3 days) with the higher suspension 
concentration (2 mg/mL), the reduction of viability for both E. coli RB and S. aureus 8325-4 cultures 
was 70-75%, and for S. epidermidis around 50%. 
Compared to MBG cultures both at short and long incubation times, E. coli RB and S. aureus showed 
a slightly lower cell viability using 2 mg/mL or 500 µg/mL of Cu_MBG 2%, respectively. At 
variance, with S. epidermidis, the difference in cell viability was dose-dependent, starting from the 
lower concentrations and becoming more evident at the higher doses (Figure 6). Interestingly, the 
results showed that MBG, although not containing copper, exhibited a slight antibacterial effect 
against the E. coli RB and S. aureus (around 25%) remaining persistent at all the tested concentrations 
(not dose-dependent). On the contrary, with S. epidermidis cultures, the obtained results highlighted a 
clear effect related to copper, suggesting a different sensitivity of bacteria to the MBG composition 
and most likely a different antibacterial mechanism of action (Figure 6). 
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In order to evaluate the influence of the released copper on the antibacterial effect, the same 
experiments were performed in parallel with both MBG and Cu_MBG 2% extracts (Figure 7). 
Overall, it was clear that there was a positive correlation between the extracts concentrations and 
bacteria growth inhibition, showing the same trend observed in the experiments based on the direct 
contact with nanoparticles. Interestingly, in all bacteria cultures, a cell viability reduction was 
observed in the samples treated with extract of Cu_MBG 2% collected after 24 h (Figure 7.B), if 
compared with extracts from MBG, hence confirming the role of copper in the observed antibacterial 
activity. The same experiments carried out with extracts of Cu_MBG 2% and MBG collected after 3 
h revealed a rather varying trend in the bacterial viability for all the tested strains, which did not allow 
a reliable interpretation of the data obtained for such short incubation times (Figure 7.A). 
 
3.5 Antibacterial effect of nanoparticles and their extracts on S. epidermidis biofilm   
S. epidermidis RP62A is known to produce considerable quantities of polysaccharide intercellular 
adhesions, inducing biofilm formation [35, 40]. To evaluate the antibacterial activity on 
staphylococcal biofilms, S. epidermidis cultures were incubated with MBG and Cu_MBG 2% 
suspensions (2 mg/mL) or with related extracts collected after 24 h of incubation, either during the 
biofilm formation or in the presence of pre-formed biofilms (Figures 8 and 9). A significant reduction 
of biofilm growth was determined when the cultures were performed in the presence of Cu_MBG 2% 
particles if compared to MBG (Figure 8.A, indicated by ***) and untreated cultures (data not shown). 
Moreover, a significant difference in cell viability was obtained when a stable formed biofilm was 
treated with MBG or Cu_MBG 2% nanoparticles (Figure 8.C, indicated by **). Conversely, these 
effects were less marked in the presence of only copper containing extracts (released by 
nanoparticles) when incubated during the biofilms formation (Figures 9.A) or on the pre-formed 
biofilms (Figures 9.C).  
Furthermore, in order to visualize the biofilms morphology after these treatments, SEM studies were 
carried out. As expected, large cellular aggregates were observed in the biofilms produced by S. 
epidermidis RP62A in all samples used as control (Figure 8.B and D; Figure 9.B and D). Conversely, 
the presence of nanoparticles during S. epidermidis biofilm formation prevented and reduced the 
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number of adherent bacteria and cluster formation, more distinctly for Cu_MBG 2% nanoparticles 
(Figure 8.B’’’). The addition of Cu_MBG 2% suspension to an already formed staphylococcal 
biofilm, promoted a visible dispersion of biofilm aggregates (Figure 8.D’’’) whereas the contact with 
MBG suspension produced a less noticeable influence on the biofilm morphology. Similar results 
were observed for biofilm growing cultures (Figure 9.B’’’) or for formed biofilms (Figure 9.D’’’) 
incubated with Cu_MBG 2% extracts, although the bacterial reduction was less evident in comparison 
to biofilms treated with Cu_MBG 2% suspensions. 
4. Discussion  
In this study, a novel therapeutic Cu-doped mesoporous SiO2-CaO glass was successfully obtained by 
a one-pot sol-gel synthesis combined with high-frequency ultrasonication treatment. This method 
allowed us to obtain Cu-containing mesoporous spheroidal particles with rather homogeneous size, 
very high exposed surface area and uniform mesoporous channels. Two different amounts of Cu2+ ion 
were incorporated inside the glass framework, leading to systems characterized by evident changes in 
terms of exposed surface area and release properties of Cu2+ ion. Specifically, the increase of copper 
amount in the synthesis had a negative effect, affecting the formation of the mesostructure and 
leading to a significant decrease of both exposed surface area and pore volume. These results confirm 
that the presence of an excess of metal ions species in the reaction plays a negative role on the 
condensation of the silica precursors and the assembly of the mesophase structure [32, 41], leading to 
a significant decrease of the exposed surface area in the obtained material.  
TEM observations further confirmed that higher amount of doping cation had an evident impact on 
the structural properties of the produced MBGs. Specifically, Cu_MBG 5%, at variance with 
Cu_MBG 2%, shows particles characterized by a marked core-shell morphology and, as highlighted 
by EDS mapping analysis, by an enrichment of copper in the core compared to the outer shell.   
The nature of incorporated copper species was analysed by XPS analysis, which evidenced a sizeable 
difference in the relative concentration of detected Cu2+ species. A first component at lower binding 
energy (933.3 eV) is consistent with values ascribed in the literature to Cu2+ cations in extra-
framework sites [42]. At variance, the component at higher binding energy, at ca 935.7 eV, much 
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higher than that for pure CuO (ca 933.8 eV) [43], is attributed to copper species with a strong 
electronic interaction with the lattice, in analogy with results obtained for Cu-doped mesoporous 
silicas [44]. Specifically, for the Cu_MBG 2% (Figure 3.A) sample most of copper species are 
characterized by binding energy (933.3 eV) typical of extra-framework sites, with a limited 
contribution of species at higher values, whereas the Cu_MBG 5% sample, as reported in Figure 3.B, 
shows a significant higher amount of Cu2+ at higher binding energy (935.7 eV). The chemical 
environment of the incorporated copper species plays an essential role in determining the different 
release behaviour observed for the samples. The Cu_MBG 2% sample showed a sustained almost 
complete release of the incorporated Cu2+, which supports the assignment proposed for the component 
at 933.3 eV to species present as counter-ions of the silica framework, located at the mesopore surface 
and thus accessible for cation-exchange reactions when soaked in SBF. On the other hand, the 
unexpected profile observed for Cu_MBG 5%, characterized by a very limited release of Cu2+ 
species, could be interpreted assuming the inaccessibility of mostly of the incorporated metal, as it is 
likely located in the particle cores or embedded into the silica walls.  
The Cu2+ release profile obtained for Cu_MBG 2% is in good agreement with that reported for Cu-
containing silica nanospheres by Wu and co-workers [32], who investigated the effect of this 
functional ion as osteoimmunomodulatory agent and as angiogenesis promoter, suggesting similar 
properties for copper when released from MBG matrices.  
The in vitro bioactive response of Cu_MBG 2%, in terms of apatite-like forming ability, assessed 
through soaking in SBF, was found to be similar to un-doped MBG systems [10]. Besides the typical 
peaks due to hydroxyapatite phase, the XRD pattern revealed the components ascribed to calcite 
precipitate. The latter is often found when bioactive glasses with a high content of calcium (at least 
30% mol of CaO) are soaked in SBF. These glasses, when in contact with water-based solutions, 
release immediately a high amount of Ca2+ ions, which, in the case of SBF, react with the carbonate 
ions present, leading to calcite precipitation within the very first hours of immersion [45-47]. 
Although the calcium content for Cu_MBG 2% sample is not as high as reported in the literature, the 
very high exposed surface, due to the presence of the mesopores, is expected to allow a high release 
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of calcium ions in terms of both the total amount and the kinetics. Calcite has been reported to be 
resorbable [48] and osteoconductive, even without the formation of a Ca-P-rich layer [49]. Therefore, 
the co-precipitation of apatite and calcite can be considered as an index of the mesoporous glass 
bioactivity [50]. 
As stated above, previous studies have documented the excellent antibacterial function of soluble 
copper compounds against many microorganisms [51, 52]. In recent years, the interest in adding 
metals (e.g. silver, copper, zinc), with proved antimicrobial activity, to innovative nanoparticles and 
nanocomposites [53], with the final aim to reduce or prevent a device-related infection, and to reduce 
or inhibit bacterial colonization has grown. In the present study, the antibacterial effect of Cu-doped 
mesoporous bioglass nanoparticles against two gram-positive bacteria (S. aureus and S. epidermidis) 
and one gram-negative (E. coli), was investigated. In agreement with the literature related to Cu-
containing nanocomposite systems [54], the results obtained in this work, confirmed that the release 
of Cu2+ ions plays a fundamental role on antimicrobial properties. The antibacterial effect and the 
mechanism of action of copper on bacteria viability is not fully elucidated yet, however, it seems to 
be mainly associated to the pleiotropic effects of copper on bacterial cells, through a multiple 
mechanism of action. The results obtained in this work evidenced that Cu-doped glass nanoparticles 
showed antimicrobial effect, highly dependent to the dose and bacterial strains. The remarkable 
difference might be attributed to the different properties of bacteria surfaces [55].  In gram-positive 
bacteria, the absence of an outer membrane and the presence of surface negatively charged 
teichuronic and lipoteichoic acids within a single lipid bilayer surrounded by a thick but porous layer 
of peptidoglycan (20–80 nm), make them attractive to positively charges [56]. Therefore, the 
inhibiting process is supposed to be most likely associated to the action of released metal ions, which 
might be easily moved inside the microbial cells or attached to the charged outer surfaces by 
electrostatic attraction, resulting in cell apoptosis via protein denaturation and disruption of cell 
membrane [57]. By contrast, gram-negative bacteria expose a highly organized compact structure, 
which acts as a permeability barrier and prevents diffusion to the inner plasma membrane for most 
high molecular weight compounds, making them less attractive to metal nanoparticles treatment. 
Moreover, the presence of copper tolerance mechanisms in E. coli [58], including the activation 
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transmembrane copper export occurring from cytoplasm into the periplasmic space or into the 
extracellular milieu and the copper sequestration by metallothioneins, can further explain the 
requirement of a higher Cu_MBG concentrations to inhibit E. coli cultures in comparison to the other 
bacterial strains. 
At variance in E. coli and S. aureus bacteria, the Cu-doped MBG antibacterial effect seems not to be 
merely due to the release of metal ions in solution, but most likely the small size and the high surface-
to-volume ratio of Cu_MBG particles, account for the activation of cell death mechanisms [59, 60]. In 
this regard, further investigations are certainly required in order to fully elucidate the mechanisms 
involved in the antimicrobial activity of the investigated systems.  
Remarkably, this non-specific mode of action of copper-based systems makes them powerful 
antimicrobial agents with an intrinsic low likelihood of inducing microbial resistance [61].  
In recent years, the number of infections associated with antibiotic-resistant bacteria has greatly 
increased. Many of these infections are caused by microorganisms growing in biofilms, complex 
bacterial communities surrounded by a self-producing extracellular polymer matrix, able to resist both 
to antibiotic action and to human immune system [62]. The formation of biofilm is a peculiar 
characteristic of S. aureus and S. epidermidis [63] that quite frequently colonise medical devices, 
causing persistent body-related infections. 
Unlike planktonic populations, bacterial cells embedded in biofilms exhibit intrinsic resistance to 
antibiotics due to several specific defence mechanisms conferred by the biofilm environment, 
including the inactivation of anti-microbial agents by exopolysaccharide (EPS), over expression of 
stress-responsive genes, oxygen gradients within the biofilm matrix and differentiation of a 
subpopulation of biofilm cells into resistant dormant cells [64, 65]. The aforementioned features of 
biofilms place them amongst the most serious problems currently faced by medicine and thus 
considerable efforts are devoted to identify novel therapies to prevent or treat biofilms. To this 
purpose, a potentially promising treatment implies metal or metal oxide nanoparticles, showing anti-
bacterial and anti-biofilm activity [66-68].  
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In the present work, the obtained data showed that Cu_MBG 2% nanoparticles, inhibited he bacterial 
growth and were also able to counteract the formation of biofilm produced by S. epidermidis and even 
to favour its dispersion.  
The evidence of biofilm inhibition and dispersion was provided both from the assessment of the 
bacterial viability and from the morphological observations of biofilm through SEM analysis. 
Cu_MBG 2% nanoparticles dramatically decreased the number of viable cells within the tested 
biofilms and SEM results shows a significant reduction of surface coverage by S. epidermidis 
biofilms. Considering the widespread occurrence and significant impact of S. epidermidis biofilms in 
a variety of clinical settings, the developed antimicrobial material offer promising opportunities for 
the prevention of infectious diseases. 
Consistent with other studies [17, 61, 69, 70], these findings provide further proof of copper 
antimicrobial effectiveness against both the bacterial growth and the biofilm formation and 
dispersion, offering a powerful alternative to traditional systemic therapies based on antibiotics.  
Antibiotic resistance is a major challenge in the treatment of infectious diseases, particularly due to 
the emergence of multidrug-resistant pathogenic strains (MDR). Thus, in perspective, the system 
proposed in the present study, due to the combination of excellent antibacterial and bioactive 
properties, represents an effective agent, alone or in synergy with complementary approaches, for the 
treatment of bacterial diseases associated to orthopaedic implant infections. The synergistic action of 
Cu-doped MBGs nanoparticles, for instance in combination with various antibiotics, could result in 
excellent inhibition of bacteria in planktonic stage, reducing the therapeutic dose to treat the bacterial 
infections and thereby reducing the toxicity risks. Moreover, based on the observed anti-biofilm 
results, it could be envisaged their application as antibacterial coatings of medical implants, to make 
these devices more resistant to the bacterial colonization and biofilm formation. 
5. Conclusions 
In this study, a novel Cu-containing mesoporous bioactive glass (Cu_MBG), in the form of spheroidal 
nanoparticles, was synthesized via an efficient one-pot synthesis procedure. The incorporation of 
copper within the SiO2-CaO framework (up to 2% mol.) led to a material characterized by very high 
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specific surface area, uniform mesopores, homogeneous distribution of copper, excellent bioactive 
behaviour and the ability to release the copper ions at a sustained rate in a biological buffer solution. 
The assessment of the antibacterial properties of Cu_MBG nanoparticles and their ionic extracts 
against E. coli, S. aureus and S. epidermidis showed a very effective antibacterial ability against all 
the tested bacteria strains, with a strain-dependent effect. A fundamental role on the observed 
antibacterial activity was ascribed to copper ions released by Cu_MBG particles, as highlighted by 
the reduction of bacterial viability in the presence of their dissolution ionic extracts. Furthermore, 
Cu_MBG 2% suspension, at proper concentration, is able to reduce and disrupt the biofilm matrix. 
Based on the these results, Cu_MBG shows a great potential as multifunctional therapeutic agent for 
preventing diseases related to infections and for stimulating bone regeneration.   
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Table 1 
Table 1: Structural features of MBG, Cu_MBG 2% and Cu_MBG 5% samples  
 
 
 
 
 
 
 
  
Samples Specific Surface  (m2 g-1) 
Pore Volume 
(cm3 g-1) 
DFT Pore Size 
(nm) 
MBG 621 1.05 2.9 
Cu_MBG 2% 550 0.26 2.6 
Cu_MBG 5% 224 0.11 2.6 
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Table 2 
Table 2: Deconvoluted contributions of Cu2p core level and relative percentages 
 
 
 
 
 
 
  
 
Peak position 
(eV) Peak area% 
Peak position 
(eV) Peak area% 
Cu_MBG 2%         933.3                   80.3                  935.7                  19.7 
Cu_MBG 5% 933.3                                     48.5                 935.7                  51.5 
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Figure captions  
Figure 1: SEM image of Cu_MBG 2% (A), EDS spectrum (B), TEM image (C) and EDS 
mapping analysis of Cu_MBG 2% (D), Si (red), O (blue), Cu (green) and Ca (yellow) are 
uniformly distributed in the nanoparticles; SEM image of Cu_MBG 5% (E), related EDS 
spectrum (inset), TEM image (F). 
Figure 2: N2 adsorption-desorption isotherms of MBG (blue), Cu_MBG 2% (red) and Cu_MBG 
5% (green) show type IV curve with H1 hysteresis, indicative of a mesoporous structure. 
Figure 3: The XPS deconvoluted spectra in the Cu2p3/2 region for Cu_MBG 2% (A) and Cu_MBG 
5% (B). 
Figure 4: Cu2+ release profiles of Cu_MBG 2% (blue) and Cu_MBG 5% (red) in SBF. 
Figure 5: SEM images of Cu_MBG 2% after 3 days (A) and 7 days (B) of soaking in SBF and 
XRD pattern of Cu_MBG 2% after soaking in SBF for 7 days (C): the peaks marked with 
asterisks are due to hydroxyapatite phase; EDX spectra of Cu_MBG 2% after 3 days (D’) and 7 
days (D’’) of soaking in SBF.   
Figure 6: Dose-dependence viability of different bacterial strains cultured with MBG and   
Cu_MBG 2% suspensions. Gram-negative (E. coli RB) and gram-positive (S. aureus 8325-4 and  
S. epidermidis RP62A) bacterial strains were incubated with MBG or Cu_MBG 2% suspensions 
with concentrations in the range of 31-2000 µg/mL. After 1 and 3 days of incubation, MTT assay 
was performed in all samples to evaluate cell viability expressed as percentage of viability 
determined in the absence of nanoparticles (set to 100%). 
 
Figure 7: Dose-dependence viability of different bacterial strains cultured with MBG and   
Cu_MBG 2% extracts. Gram-negative (E. coli RB) and gram-positive (S. aureus 8325-4 and           
S. epidermidis RP62A) bacterial strains were incubated without (control) or with increasing serial 
dilutions of the extracts collected after 3 (A) and 24 h (B) from 2 mg/mL suspension of MBG or 
Cu_MBG 2% nanoparticles, respectively. After 1 day of incubation, MTT assay was performed in 
all samples to evaluate the viability expressed as percentage of bacterial viability compared to 
control (set to 100%). 
 
Figure 8: Bacterial viability and morphology of biofilms treated with MBG and Cu_MBG 2% 
suspensions (2 mg/mL). Both MBG or Cu_MBG 2% suspensions were added to S. epidermidis 
RP62A biofilm formation cultures (A) or after the formation of a stable staphylococcal biofilm 
(C). The biofilms cell viability was measured with the MTT assay after 24h of incubation in both 
experimental conditions. Results were expressed as percentage of the control (w/o nanoparticles). 
SEM representative images of the staphylococcal biofilms formed in the absence (control) or in 
contact with both types of nanoparticles for 24h are shown (B). SEM images of post formed 
biofilms, untreated (control) or treated with both MBG or Cu_MBG 2% nanoparticles for 24h, are 
also presented (D). Magnification, 2kx. 
 
Figure 9: Bacterial viability and morphology of biofilms treated with extracts of MBG and 
Cu_MBG 2%. Undiluted supernatants collected at 24h from 2 mg/mL of both types of 
nanoparticle suspensions were added to S. epidermidis RP62A biofilm growing cultures (A) or 
after the formation of a stable staphylococcal biofilm (C). The biofilm viability was measured 
with the MTT assay after 24h of incubation. Results were expressed as percentage of the control. 
SEM images of staphylococcal biofilm formed without (control) or with extracts for 24h are 
shown (B). SEM images of post formed biofilms, incubated w/o (control) or with extracts for 24h 
are also presented (D). Magnification, 2kx. 
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Supplementary material 
Figure SI.1: XRD patterns of Cu_MBG 2% and Cu_ MBG 5%: the broad peak at 23° corresponded to 
amorphous silica, and no diffraction peaks of copper oxide (CuOx) are observed in both samples. 
 
 
Statement of Significance  
 
In order to endow mesoporous bioactive glass, characterized by excellent bioactive 
properties, with additional biological functions, Cu-doped mesoporous SiO2-CaO 
glass (Cu-MBG) in the form of nanoparticles was prepared by an ultra-sound assisted 
one pot synthesis.  
The analysis of the bacterial viability, using different bacterial strains, and the 
morphological observation of the biofilm produced by the Staphylococcus 
epidermidis, revealed the antimicrobial effectiveness of the Cu-MBG and the relative 
ionic extracts against both the bacterial growth and the biofilm formation/dispersion, 
providing a true alternative to traditional antibiotic systemic therapies. 
The proposed multifunctional agent represents a promising and versatile platform for 
bone and soft tissues regeneration.  
 
 
